The protein purification resin market sits at an evaluation of US$ 5.7 billion in 2022 and is projected to reach a market share of US$ 13.8 billion in 2032. The market is said to expand at a staggering CAGR of 9.3% during the forecast period from 2022 to 2032.
The key market driving factor of the global protein purification resin market is the increasing accessibility of non-governmental and governmental funds coupled with increased expenditure on research and development activities across the world.
| Attributes | Details |
|---|---|
| Protein Purification Resin Market CAGR | 9.3% |
| Protein Purification Resin Market Size (2021) | US$ 5.7 Billion |
| Protein Purification Resin Market Size (2032) | US$ 13.8 Billion |
Since several government organizations are spending on numerous research and development activities, the demand for protein purification resin is primarily used to meet this requirement. Protein purification resin is generally used in pharmaceutical and academic research facilities and laboratories for several protein purification technologies like high-performance liquid chromatography, affinity chromatography, and fast protein liquid chromatography.
Protein purification resin is used for the efficient, convenient, and consistent splitting of antibodies and proteins from the crude samples during the downstream processing. Protein purification resins are agarose-based, silica-based, Sepharose-based, etc. Protein research involves techniques such as separation, concentration, and stabilization, and they eradicate contaminants such as viruses, endotoxins, and nucleic acid. The techniques consist of verifying and maintaining a purification table to trace the development of the enzyme. They are generally used to categorize a protein’s function, interactions, and structure.
The sales of protein purification resin are on the rise owing to more expenditure on research and development activities, and an increase in the prevalence of governmental and non-governmental funds is promoting the growth of the global protein purification resin market. The COVID-19 pandemic resulted in an interruption in the protein purification procedure, and this negatively impacted the global market. However, presently the additional funds aimed toward research and development are a breather for the market and helping it recover the loss incurred during the pandemic.
The demand for protein purification resin is primarily for the use of this technique in downstream processing in academic institutes, research and development, and the pharmaceutical industry.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Governments across the world are actively investing in research and development and setting out initiatives that boost the development and growth of the biotechnology and pharmaceutical markets. The supportive governments are also providing several benefits through grants, tax incentives, and investment-friendly regulations, amongst others.
The demand for the protein purification resin market is higher in the pharmaceutical industry owing to considerable investments in the development of the biomarker-specific molecule. The protein purification resin market is growing owing to lucrative funding from both private and public research organizations for protein research and increasing research in the structural-based drug design field.
Technological advancements such as automated purification instruments and single-use technologies are also fuelling the growth of the protein purification resin market. Also, the increasing trend of Contract Research Organizations (CRO) is creating an upsurge in demand for protein purification resin.
The increasing prevalence of disease and several other health issues has resulted in additional consumption of pharmaceutical products, and this is said to promote the growth of this market during the forecast years.
In the pharmaceutical industry, the most crucial factor is the purity of the protein. The protein purification resin is utilized in the pharmaceutical industry in medium- and small-scale downstream processing. In developing regions, the rate of expansion of the pharmaceutical industry is higher, and this is creating opportunities and will support the global protein purification resin market.
Several protein purification resin manufacturers across the world are constantly inventing and launching novel products which are suitable for varied parameters such as low-pressure to medium-pressure liquid chromatography. The easy accessibility of innovative and novel protein purification resin products is escalating the demand and sales of the products in the global market.
The global protein purification resin market can be divided into seven distinctive regions. In developed nations, rapid industrialization and innovation will continue to drive the sales of protein purification resin expansion.
North America is responsible for the biggest market share of the global protein purification resin market followed by Europe. These regions possess strong research and development field and the support from the pharmaceutical industry are backing the increased consumption of protein purification resin in the global market by the countries of these regions.
Also, in North America, the funding for life science research is higher, this region also has the presence of key market players and established research infrastructure. These factors will promote the growth of the protein purification resin market in this region.
Asia Pacific is anticipated to garner the highest growth rate in the global protein purification resin market. This is due to larger research and development activities in this region which will boost the consumption of protein purification resin in the global market. Developing countries such as China and India have increased initiatives undertaken by their governments. Also, the governments of these countries are supporting funds for the development of new and inventive purification methods.
Principal Consultant
A few global protein purification resin market key players are Promega Corporation, Labome, Pall Corporation, IBA GmbH, Takara Bio Inc., Purolite Life Sciences, BioVision Incorporated, Westburg BV, Roche Holding AG, Sterogene Bioseparations, Expedeon Ltd., Thermo-Fisher Scientific, Mayflower Bioscience, Merck KGaA, Molecular Cloning Laboratories.
These players are using numerous strategies, such as mergers & acquisitions, partnerships, collaborations, etc., to strengthen their market position and augment the sales of protein purification resin. For instance, in February 2022, Merck KGaA which is a leader in science and technology, declared the closure of transactions to acquire Exelead, after the regulatory clearances and execution of other mandatory closing conditions for nearly USD 780 million in cash.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9.3% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global protein purification resin market is set to advance at a CAGR of 9.3% from 2022 to 2032.
North America followed by Europe is likely to hold a major protein purification resin market share during the forecast period.
The Protein Purification Resin market is expected to reach US$ 13.8 billion by 2032.
1. Executive Summary | Protein Purification Resin Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and Their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyers 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Type, 2022 to 2032 5.3.1. Protein A 5.3.2. Protein G 5.3.3. Protein L 5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End Use 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By End Use, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By End Use, 2022 to 2032 6.3.1. Pharmaceutical 6.3.2. Research Laboratories 6.3.3. Academic Research Institute 6.4. Y-o-Y Growth Trend Analysis By End Use, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End Use, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Distribution Channel, 2017 to 2021 7.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Distribution Channel, 2022 to 2032 7.3.1. Direct Sales 7.3.2. Indirect Sales 7.3.2.1. Specialty Stores 7.3.2.2. Online Retail 7.3.2.3. Other Retail Format 7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2021 7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022 to 2032 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2017 to 2021 8.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2022 to 2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Type 9.2.3. By End Use 9.2.4. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By End Use 9.3.4. By Distribution Channel 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Type 10.2.3. By End Use 10.2.4. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By End Use 10.3.4. By Distribution Channel 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Type 11.2.3. By End Use 11.2.4. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By End Use 11.3.4. By Distribution Channel 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. New Zealand 12.2.1.8. Rest of Asia Pacific 12.2.2. By Type 12.2.3. By End Use 12.2.4. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By End Use 12.3.4. By Distribution Channel 12.4. Key Takeaways 13. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of Middle East and Africa 13.2.2. By Type 13.2.3. By End Use 13.2.4. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By End Use 13.3.4. By Distribution Channel 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Type 14.1.2.2. By End Use 14.1.2.3. By Distribution Channel 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Type 14.2.2.2. By End Use 14.2.2.3. By Distribution Channel 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Type 14.3.2.2. By End Use 14.3.2.3. By Distribution Channel 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Type 14.4.2.2. By End Use 14.4.2.3. By Distribution Channel 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Type 14.5.2.2. By End Use 14.5.2.3. By Distribution Channel 14.6. United Kingdom 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Type 14.6.2.2. By End Use 14.6.2.3. By Distribution Channel 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Type 14.7.2.2. By End Use 14.7.2.3. By Distribution Channel 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Type 14.8.2.2. By End Use 14.8.2.3. By Distribution Channel 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Type 14.9.2.2. By End Use 14.9.2.3. By Distribution Channel 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Type 14.10.2.2. By End Use 14.10.2.3. By Distribution Channel 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Type 14.11.2.2. By End Use 14.11.2.3. By Distribution Channel 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Type 14.12.2.2. By End Use 14.12.2.3. By Distribution Channel 14.13. Malaysia 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Type 14.13.2.2. By End Use 14.13.2.3. By Distribution Channel 14.14. Singapore 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Type 14.14.2.2. By End Use 14.14.2.3. By Distribution Channel 14.15. Australia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Type 14.15.2.2. By End Use 14.15.2.3. By Distribution Channel 14.16. New Zealand 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Type 14.16.2.2. By End Use 14.16.2.3. By Distribution Channel 14.17. GCC Countries 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Type 14.17.2.2. By End Use 14.17.2.3. By Distribution Channel 14.18. South Africa 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Type 14.18.2.2. By End Use 14.18.2.3. By Distribution Channel 14.19. Israel 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Type 14.19.2.2. By End Use 14.19.2.3. By Distribution Channel 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Type 15.3.3. By End Use 15.3.4. By Distribution Channel 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Promega Corporation 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Labome 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Pall Corporation 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. IBA GmbH 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Takara Bio Inc. 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Purolite Life Sciences 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. BioVision Incorporated 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Westburg BV 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Roche Holding AG 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Sterogene Bioseparations 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. Expedeon Ltd. 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 16.1.12. Thermo-Fisher Scientific 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.12.5.2. Product Strategy 16.1.12.5.3. Channel Strategy 16.1.13. Mayflower Bioscience 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.13.5.2. Product Strategy 16.1.13.5.3. Channel Strategy 16.1.14. Merck KGaA 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.14.5.2. Product Strategy 16.1.14.5.3. Channel Strategy 16.1.15. Molecular Cloning Laboratories 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 16.1.15.5.2. Product Strategy 16.1.15.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Packaging Insights
View Reports
Protein Purification Resin Market
